Company profile for Processa Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Processa Pharmaceuticals (OTCMKTS: PCSA) was formed in October 2017 as a result of an asset acquisition of Promet Therapeutics, LLC by Heatwurx, Inc (OTCMKTS: HUWX). Processa's mission is to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. The company is headquartered in Hanover, Maryland. To advance its mission, Processa has assembled an unparalleled Manage...
Processa Pharmaceuticals (OTCMKTS: PCSA) was formed in October 2017 as a result of an asset acquisition of Promet Therapeutics, LLC by Heatwurx, Inc (OTCMKTS: HUWX). Processa's mission is to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. The company is headquartered in Hanover, Maryland. To advance its mission, Processa has assembled an unparalleled Management Team, Board of Directors and Product Development Team. The Processa Team are experts in developing drug products from IND enabling studies to NDA submission.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
7380 Coca Cola Drive Suite 106 Hanover, MD 21076
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/05/3181589/0/en/Processa-Pharmaceuticals-Announces-Poster-Presentation-of-Adaptive-Phase-2-3-PCS499-Study-in-FSGS-at-ASN-Kidney-Week-2025.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/08/07/3129263/0/en/Processa-Pharmaceuticals-Secures-Strategic-Investment-and-Evaluates-Corporate-Crypto-Treasury-Strategies.html

GLOBENEWSWIRE
07 Aug 2025

https://www.globenewswire.com/news-release/2025/07/01/3108392/0/en/Processa-Pharmaceuticals-Provides-Portfolio-and-Business-Update.html

GLOBENEWSWIRE
01 Jul 2025

https://www.globenewswire.com/news-release/2025/06/17/3100689/0/en/Processa-Pharmaceuticals-Signs-Binding-Term-Sheet-Granting-Intact-Therapeutics-Exclusive-Option-to-License-Phase-2-Gastroparesis-Drug-Candidate.html

GLOBENEWSWIRE
17 Jun 2025

https://www.globenewswire.com/news-release/2025/06/13/3098971/0/en/Processa-Pharmaceuticals-to-Engage-Potential-Partners-and-Investors-at-BIO-International-Convention-2025.html

GLOBENEWSWIRE
13 Jun 2025

https://www.globenewswire.com/news-release/2025/05/30/3091075/0/en/Processa-Pharmaceuticals-Announces-Presentation-and-Publication-of-Three-Abstracts-at-2025-ASCO-Annual-Meeting.html

GLOBENEWSWIRE
30 May 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty